Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

60%

3 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 3
2(50.0%)
N/A
1(25.0%)
Phase 4
1(25.0%)
4Total
Phase 3(2)
N/A(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06526117Phase 4Recruiting

Stroke Prevention in Nigeria 2 Trial

Role: collaborator

NCT06397118Not ApplicableActive Not Recruiting

Prevention of Malnutrition in Children With Sickle Cell Disease

Role: collaborator

NCT04800809Completed

The Afolabi Stroke Registry for Children and Young Adults With SCD in Northern Nigeria

Role: collaborator

NCT02675790Phase 3Completed

Moderate Dose Hydroxyurea for Secondary Stroke Prevention in Children With Sickle Cell Disease in Sub-Saharan Africa

Role: collaborator

NCT02560935Phase 3Completed

Primary Prevention of Stroke in Children With SCD in Sub-Saharan Africa II

Role: collaborator

All 5 trials loaded